Home › Funds › Citadel Advisors › FHTX
Citadel Advisors position in FHTX
FOGHORN THERAPEUTICS INC · Health Care
Latest position (Q2 2026)158.82K sh
Reported value held$775.05K
Portfolio Weight0.00%
First reportedQ4 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 12.00K | $274.00K | New |
| Q1 2022 | 58.55K | $892.00K | Add |
| Q3 2022 | 105.89K | $909.00K | New |
| Q4 2022 | 105.58K | $673.61K | Hold |
| Q1 2023 | 156.37K | $969.51K | Add |
| Q1 2024 | 32.97K | $221.25K | New |
| Q2 2024 | 72.55K | $417.16K | Add |
| Q3 2024 | 92.20K | $858.42K | Add |
| Q3 2025 | 12.03K | $58.81K | New |
| Q4 2025 | 182.28K | $984.29K | Add |
| Q1 2026 | 200.01K | $956.06K | Add |
| Q2 2026 | 158.82K | $775.05K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding FHTX
- Fidelity Management & Research (FMR) 5.71M sh · $27.85M · Q2 2026
- BlackRock Inc 2.63M sh · $12.82M · Q2 2026
- Vanguard Group 1.93M sh · $10.42M · Q4 2025
- Geode Capital Management 910.87K sh · $4.45M · Q2 2026
- Renaissance Technologies 377.94K sh · $1.84M · Q2 2026
- Northern Trust Corp 309.77K sh · $1.51M · Q2 2026
- Goldman Sachs Group 164.26K sh · $801.57K · Q2 2026
- Charles Schwab Investment Management 109.78K sh · $535.73K · Q2 2026
- Morgan Stanley 92.10K sh · $449.43K · Q2 2026
- BNY Mellon 79.36K sh · $387.25K · Q2 2026
- Invesco Ltd 78.14K sh · $381.30K · Q2 2026